RhumbLine Advisers
IMA

RhumbLine Advisers’s ImageneBio Inc IMA Stock Holding History

RhumbLine Advisers’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-321
Closed -$6.36K – 4260
2024
Q2 		$6.36K Sell
321
-1,997
-86% -$35.3K ﹤0.01% 4047
2024
Q1 		$39.5K Buy
2,318
+75
+3% +$1.37K ﹤0.01% 3677
2023
Q4 		$53K Buy
2,243
+128
+6% +$4.17K ﹤0.01% 3619
2023
Q3 		$110K Buy
2,115
+329
+18% +$19.8K ﹤0.01% 3433
2023
Q2 		$141K Buy
+1,786
New +$128K ﹤0.01% 3401
2022
Q2 		– Sell
-2,397
Closed -$175K – 3163
2022
Q1 		$175K Buy
2,397
+55
+2% +$5.85K ﹤0.01% 2787
2021
Q4 		$352K Buy
+2,342
New +$380K ﹤0.01% 2653

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return

RhumbLine Advisers's IMA Position: Q3 2024 in Review

RhumbLine Advisers sold out of ImageneBio Inc (IMA) in Q3 2024, closing a stake of 321 shares — an estimated $6.36K sold.

RhumbLine Advisers first reported a position in IMA in Q4 2021 and held it in 7 quarters. The position peaked at $352K in Q4 2021. 57 funds tracked by Wall St. Rank hold IMA as of Q3 2024.

  • RhumbLine Advisers reported no remaining ImageneBio Inc position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 321 ImageneBio Inc shares in Q3 2024, an estimated $6.36K.
  • RhumbLine Advisers first reported a position in ImageneBio Inc in Q4 2021 and held it in 7 quarters.
  • RhumbLine Advisers's ImageneBio Inc position peaked at $352K in Q4 2021.
  • 57 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.